Minimum Investment
From €500,000
Investment Term
7.5 years
Golden Visa Eligible
CMVM Regulated Fund
Invest in High-Growth Companies in the Health & Life Sciences sector Portuguese residency, with permanent residency from year five
This fund is a private equity fund focused on high-growth companies in the Health and Life Sciences sector across Southern Europe, South America, and Israel. The fund strategically invests in companies with strong and disruptive R&D capabilities, emphasizing areas such as oncology, mental health, obesity, and cardiovascular diseases which are key contributors to global mortality.
The investment approach, balances early-stage innovation with growth and consolidation strategies, and leverages emerging technologies like AI, genomics, and digital health solutions. The fund also maximizes returns and mitigates risks through EU grants and matching funds, benefiting from ESG integration and a robust management structure.
Portugal Golden Visa Investment Fund Terms:
- Fund Size: €50 million
- Minimum Investment to qualify for the Golden Visa: €500,000
- Fund Type: Private Equity Fund
- Fund Term: 7.5 Years
- Citizenship Eligibility: 10 years, 7 for EU and CPLP nationals*
- Management Fee: 2% over committed/ invested capital
- Set Up Fee: 2% one-off over committed capital
*Since Lei Orgânica n.º 1/2026, naturalisation requires ten years of legal residence, seven for EU and CPLP nationals, counted from the issue of the residence title. Permanent residency remains available from year five. Applicants must hold the investment, spend 7 days in Portugal in the first year and 14 days in each subsequent two-year period, and reach A2 Portuguese.
